Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomedicine
California Healthcare Institute Supports Introduction of Biosimilars Legislation
April 5th, 2008
The California Healthcare Institute (CHI) submitted a letter on Friday, March 14, to Congresswoman Anna Eshoo (D-Menlo Park) commending her for the introduction of H.R. 5629, the "Pathway for Biosimilars Act," legislation that would create a science-based approach for U.S. Food and Drug Administration (FDA) approval of follow-on biologics, while preserving important provisions necessary to encourage future biomedical innovation. CHI is a non-profit public policy research organization for California's biomedical industry. California's biotechnology industry leads the world in the development of innovative medicines, giving hope to patients with devastating diseases like...
Source: Law & Health Weekly (2008-04-05)
|
